Gaya JM - Search Results

1

Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma.

Cosentino M, Palou J, Gaya JM, Breda A, Rodriguez-Faba O, Villavicencio-Mavrich H. Cosentino M, et al. Among authors: gaya jm. World J Urol. 2013 Feb;31(1):141-5. doi: 10.1007/s00345-012-0877-2. Epub 2012 May 3. World J Urol. 2013. PMID: 22552732

2

The case for conservative management in the treatment of patients with non-muscle-invasive micropapillary bladder carcinoma without carcinoma in situ.

Gaya JM, Palou J, Algaba F, Arce J, Rodríguez-Faba O, Villavicencio H. Gaya JM, et al. Can J Urol. 2010 Oct;17(5):5370-6. Can J Urol. 2010. PMID: 20974029

3

Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma.

Arce J, Gaya JM, Huguet J, Rodriguez O, Palou J, Villavicencio H. Arce J, et al. Among authors: gaya jm. Can J Urol. 2011 Feb;18(1):5529-36. Can J Urol. 2011. PMID: 21333045

4

Alloplastic bladder substitution: are we making progress?

Cosentino M, Gaya JM, Breda A, Palou J, Villavicencio H. Cosentino M, et al. Among authors: gaya jm. Int Urol Nephrol. 2012 Oct;44(5):1295-303. doi: 10.1007/s11255-012-0249-2. Epub 2012 Jul 21. Int Urol Nephrol. 2012. PMID: 22821051 Review.

5

ΔNp63 expression is a protective factor of progression in clinical high grade T1 bladder cancer.

Gaya JM, López-Martínez JM, Karni-Schmidt O, Bonal DM, Algaba F, Palou J, Villavicencio H, Benson MC, Cordon-Cardo C, Castillo-Martin M. Gaya JM, et al. J Urol. 2015 Apr;193(4):1144-50. doi: 10.1016/j.juro.2014.10.098. Epub 2014 Oct 28. J Urol. 2015. PMID: 25444981

6

Urothelial carcinoma in situ: concerns about daily practice.

Palou J, Rodriguez O, Gaya JM. Palou J, et al. Among authors: gaya jm. Eur Urol. 2015 May;67(5):889-90. doi: 10.1016/j.eururo.2014.12.030. Epub 2015 Jan 6. Eur Urol. 2015. PMID: 25576008 No abstract available.

7

[Endoscopic bladder neck incision as first step in radical prostatectomy: An aid for patients previously treated for Bladder outlet obstruction].

Gaya JM, Palou J, Palazzetti A, Novoa A, Fernández M, Gausa L, Peña JA, Villavicencio H. Gaya JM, et al. Arch Esp Urol. 2015 Sep;68(7):587-94. Arch Esp Urol. 2015. PMID: 26331399 Spanish.

8

Laparoscopic Management of Ureteroileal Anastomosis Strictures: Initial Experience.

Rosales A, Emiliani E, Salvador JT, Peña JA, Gaya JM, Palou J, Villavicencio H. Rosales A, et al. Among authors: gaya jm. Eur Urol. 2016 Sep;70(3):493-8. doi: 10.1016/j.eururo.2016.02.045. Epub 2016 Feb 28. Eur Urol. 2016. PMID: 26928378

9

Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette-Guérin immunotherapy?

Golabek T, Palou J, Rodríguez O, Gaya JM, Breda A, Villavicencio H. Golabek T, et al. Among authors: gaya jm. World J Urol. 2017 Feb;35(2):237-243. doi: 10.1007/s00345-016-1856-9. Epub 2016 Jun 9. World J Urol. 2017. PMID: 27277599

10

[Surgical treatment of local disease in metastatic prostate cancer.].

Gaya JM, Huguet J, Breda A, Palou J. Gaya JM, et al. Arch Esp Urol. 2018 Mar;71(3):288-297. Arch Esp Urol. 2018. PMID: 29633950 Free article. Review. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters